Clinical Research Management Briefing - December 11, 2017
Tech-savvy Millennials could be the change agent clinical trial research needs to move past legacy tools, inefficient processes and siloed communication.
Forbes, December 5
New research finds that close attention from the U.S. Food and Drug Administration (FDA) significantly influences the efficacy of drug development acceleration programs.
Los Angeles Times, December 5
A lawsuit filed by the Center for Responsible Science (CRS) against the FDA in regard to clinical trial participant risks shines a light on informed consent guidance.
Clinical Leader, December 5
Financial and Operations
More efficient clinical trials are key to lowering prescription drug prices, but automation alone is not enough to meaningfully expedite or simplify the research process.
Forbes, December 6
Promising clinical studies backed by multiple major pharmaceutical companies could be a turning point for migraine prevention and treatment.
ScienceAlert, December 4